"All in" for a huge pot: the PROWESS-SHOCK trial for refractory septic shock.
Barie
Philip S
PS
D000890:Anti-Infective Agents / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D011486:Protein C / Q000191:economics / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D012772:Shock, Septic / Q000188:drug therapy*
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated